Samsara BioCapital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Memento MedicinesJun 2026
Privately-held biotech company developing biologic therapies for retinal diseases
BiotechBoston, US
William Daley Bonificio(Executive Officer, Promoter)Megan Krench(Director)Stephen Basil Thomas(Executive Officer, Promoter)Naveen Manu Daryani(Executive Officer, Director, Promoter)Vishal Kapoor(Director)
BoardZach Scheiner(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.